North America Sterile Compounding Pharmacies Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous)


No. of Pages: 100    |    Report Code: TIPRE00027147    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
North America Sterile Compounding Pharmacies Market

The sterile compounding pharmacies market in North America is expected to grow from US$ 1,997.45 million in 2021 to US$ 3,218.93 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.

Personalized medicine has gained significant attention due to its specific drug delivery and dosing capabilities. According to the report published by Personalized Medicine Coalition, personalized medicines accounted for more than a quarter of all new therapeutics approved since 2015. For instance, the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) approved 53 new molecular entities (NMEs) in 2020. Among the 49 therapeutics NMES, 19 (almost 39%) are personalized medicines. This is the highest percentage since 2018, where personalized medicines accounted for 42% of the newly approved NMEs. Sterile compounding medications act as the best alternative for traditional pharmacy compounding practices, especially for meeting specific medical needs of patients that the FDA-approved drugs cannot meet. For example, sterile compounding pharmacies offer customized (personalized) formulations, such as injectable drugs, via different administration routes to create dosages as per patients' requirements related to strengths or forms that can eliminate components of FDA-approved drugs that patients are allergic to. Moreover, in some cases, where patients do not respond to traditional forms of treatment or need a different administration route with diverse strengths, sterile products fulfill these needs by offering customized patient solutions. With compounding being considered an essential part of customized medicine, the accelerating demand for precision therapies in recent years has opened new revenue streams for sterile compounding pharmacies. Several key players have begun to focus on inorganic growth strategies for innovating and developing efficient products, which is further anticipated to drive the market in North America.

 

Both community and hospital compounding units were heavily involved in managing the COVID-19 pandemic. The increased demand for personal protective equipment (PPE) and other supplies has left many hospitals struggling to maintain the integrity and safety of their sterile compounding operations. Also, during the pandemic situation, United States Pharmacopeia (USP) published a new guidance document addressing operational concerns regarding sterile compounding during the COVID-19 crisis. Hospitals are taking seriously the need to adjust their approaches to sterile compounding due to COVID-19 related equipment shortages. The degree of adjustment needed varies widely from day to day and institution to institution. Apart from that, as per the report released by the Government of Canada, the pandemic has created a number of challenges for businesses. For example, disruptions in supply chain and distribution chains and the limited availability of contract service providers affect the ability to perform tasks such as external calibration and specialized equipment maintenance. Thus, the aforementioned factors have highly impacted the sterile compounding pharmacies market.

 

North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

North America Sterile Compounding Pharmacies Market Segmentation        

 

North America Sterile Compounding Pharmacies Market – By Product

  • Injectable Drugs
  • Infusions

North America Sterile Compounding Pharmacies Market – By Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous

North America Sterile Compounding Pharmacies Market– By Country

  • US
  • Canada
  • Mexico

North America Sterile Compounding Pharmacies Market-Companies Mentioned

  • Avella Specialty Pharmacy
  • B. Braun Melsungen AG
  • Fagron, Inc.
  • Fresenius Kabi AG
  • Pace Pharmacy
  • Pavilion Compounding Pharmacy, LLC.
  • Pencol Compounding Pharmacy
  • PharMEDium Healthcare Holdings, Inc.
  • SandsRx
  • Triangle Compounding Pharmacy

North America Sterile Compounding Pharmacies Strategic Insights

Strategic insights for the North America Sterile Compounding Pharmacies provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-sterile-compounding-pharmacies-market-strategic-framework.webp
Get more information on this report

North America Sterile Compounding Pharmacies Report Scope

Report Attribute Details
Market size in 2021 US$ 1,997.45 Million
Market Size by 2028 US$ 3,218.93 Million
Global CAGR (2021 - 2028) 7.1%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Injectable Drugs and Infusions
By Route of Administration
  • Intravenous
  • Intramuscular
  • Subcutaneous
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Avella Specialty Pharmacy
  • B. Braun Melsungen AG
  • Fagron, Inc.
  • Fresenius Kabi AG
  • Pace Pharmacy
  • Pavilion Compounding Pharmacy, LLC.
  • Pencol Compounding Pharmacy
  • PharMEDium Healthcare Holdings, Inc.
  • SandsRx
  • Triangle Compounding Pharmacy
  • Get more information on this report

    North America Sterile Compounding Pharmacies Regional Insights

    The geographic scope of the North America Sterile Compounding Pharmacies refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/north-america-sterile-compounding-pharmacies-market-geography.webp
    Get more information on this report

    The List of Companies - North America Sterile Compounding Pharmacies Market

    1. Avella Specialty Pharmacy
    2. B. Braun Melsungen AG
    3. Fagron, Inc.
    4. Fresenius Kabi AG
    5. Pace Pharmacy
    6. Pavilion Compounding Pharmacy, LLC.
    7. Pencol Compounding Pharmacy
    8. PharMEDium Healthcare Holdings, Inc.
    9. SandsRx
    10. Triangle Compounding Pharmacy
    Frequently Asked Questions
    How big is the North America Sterile Compounding Pharmacies Market?

    The North America Sterile Compounding Pharmacies Market is valued at US$ 1,997.45 Million in 2021, it is projected to reach US$ 3,218.93 Million by 2028.

    What is the CAGR for North America Sterile Compounding Pharmacies Market by (2021 - 2028)?

    As per our report North America Sterile Compounding Pharmacies Market, the market size is valued at US$ 1,997.45 Million in 2021, projecting it to reach US$ 3,218.93 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.

    What segments are covered in this report?

    The North America Sterile Compounding Pharmacies Market report typically cover these key segments-

    • Product (Injectable Drugs and Infusions)
    • Route of Administration (Intravenous, Intramuscular, Subcutaneous)

    What is the historic period, base year, and forecast period taken for North America Sterile Compounding Pharmacies Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Sterile Compounding Pharmacies Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in North America Sterile Compounding Pharmacies Market?

    The North America Sterile Compounding Pharmacies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Avella Specialty Pharmacy
  • B. Braun Melsungen AG
  • Fagron, Inc.
  • Fresenius Kabi AG
  • Pace Pharmacy
  • Pavilion Compounding Pharmacy, LLC.
  • Pencol Compounding Pharmacy
  • PharMEDium Healthcare Holdings, Inc.
  • SandsRx
  • Triangle Compounding Pharmacy
  • Who should buy this report?

    The North America Sterile Compounding Pharmacies Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Sterile Compounding Pharmacies Market value chain can benefit from the information contained in a comprehensive market report.